PT1250148E - Uso de fsh para o tratamento da infertilidade - Google Patents

Uso de fsh para o tratamento da infertilidade

Info

Publication number
PT1250148E
PT1250148E PT01900491T PT01900491T PT1250148E PT 1250148 E PT1250148 E PT 1250148E PT 01900491 T PT01900491 T PT 01900491T PT 01900491 T PT01900491 T PT 01900491T PT 1250148 E PT1250148 E PT 1250148E
Authority
PT
Portugal
Prior art keywords
fsh
infertility
treatment
Prior art date
Application number
PT01900491T
Other languages
English (en)
Portuguese (pt)
Inventor
Ernest Loumaye
Louise Duerr-Meyers
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26072975&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1250148(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP00302840A external-priority patent/EP1142582A1/en
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of PT1250148E publication Critical patent/PT1250148E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT01900491T 2000-01-27 2001-01-09 Uso de fsh para o tratamento da infertilidade PT1250148E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00300591 2000-01-27
EP00302840A EP1142582A1 (en) 2000-04-04 2000-04-04 Use of FSH for treating infertility

Publications (1)

Publication Number Publication Date
PT1250148E true PT1250148E (pt) 2004-09-30

Family

ID=26072975

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01900491T PT1250148E (pt) 2000-01-27 2001-01-09 Uso de fsh para o tratamento da infertilidade

Country Status (29)

Country Link
US (1) US7291593B2 (enExample)
EP (2) EP1442748A1 (enExample)
JP (1) JP5170928B2 (enExample)
KR (2) KR100871502B1 (enExample)
CN (1) CN1418107A (enExample)
AR (1) AR027287A1 (enExample)
AT (1) ATE267608T1 (enExample)
AU (1) AU783121B2 (enExample)
BG (1) BG65915B1 (enExample)
BR (1) BR0107881A (enExample)
CA (1) CA2397680A1 (enExample)
CZ (1) CZ302835B6 (enExample)
DE (1) DE60103503T3 (enExample)
DK (1) DK1250148T4 (enExample)
EA (1) EA004924B1 (enExample)
EE (1) EE05444B1 (enExample)
ES (1) ES2217113T5 (enExample)
HR (1) HRP20020630A2 (enExample)
HU (1) HU230833B1 (enExample)
IL (2) IL150837A0 (enExample)
MX (1) MXPA02007233A (enExample)
NO (1) NO324626B1 (enExample)
PL (1) PL211113B1 (enExample)
PT (1) PT1250148E (enExample)
RS (1) RS50805B (enExample)
SI (1) SI1250148T2 (enExample)
SK (1) SK287717B6 (enExample)
TR (1) TR200401810T4 (enExample)
WO (1) WO2001054715A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002324183B2 (en) * 2001-09-12 2007-10-25 Merck Serono Sa Use of hCG and LH in controlled ovarian hyperstimulation
PL369098A1 (en) * 2001-09-12 2005-04-18 Applied Research Systems Ars Holding N.V. Use of hcg in controlled ovarian hyperstimulation
PL369021A1 (en) * 2001-09-12 2005-04-18 Applied Research Systems Ars Holding N.V. Use of hcg and lh in controlled ovarian hyperstimulation
UA88879C2 (en) * 2003-09-02 2009-12-10 Эплайд Рисерч Системз Эрс Холдинг Н.В. Fsh glycosylation mutant
US7481748B2 (en) * 2005-09-22 2009-01-27 Kurt Manufacturing Company, Inc. Locking mechanism for a bicycle trainer
WO2008140794A1 (en) * 2007-05-11 2008-11-20 The Texas A & M University System Hormone normalization therapy and uses thereof
AR081755A1 (es) 2010-04-02 2012-10-17 Hanmi Holdings Co Ltd Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo
CA2934579A1 (en) * 2013-12-20 2015-06-25 Fertilify Inc. Compositions comprising vitamin c, vitamin e, and coenzyme q10 and use thereof for promoting female fertility and reproductive health
AR112541A1 (es) * 2017-09-01 2019-11-06 Ferring Bv Composición para estimulación ovárica controlada con hef recombinante

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725579A (en) * 1985-02-21 1988-02-16 Serono Laboratories, Inc. Method of in vitro fertilization by a unique combination of gonadotropins

Also Published As

Publication number Publication date
NO20023354L (no) 2002-09-24
PL356925A1 (en) 2004-07-12
DK1250148T4 (da) 2008-09-22
AU2532101A (en) 2001-08-07
CZ302835B6 (cs) 2011-11-30
JP2003520823A (ja) 2003-07-08
PL211113B1 (pl) 2012-04-30
KR20020081273A (ko) 2002-10-26
SI1250148T2 (sl) 2008-10-31
ES2217113T3 (es) 2004-11-01
DE60103503D1 (de) 2004-07-01
EA200200801A1 (ru) 2003-02-27
AU783121B2 (en) 2005-09-29
HRP20020630A2 (en) 2004-12-31
TR200401810T4 (tr) 2004-09-21
EP1442748A1 (en) 2004-08-04
CA2397680A1 (en) 2001-08-02
DK1250148T3 (da) 2004-08-16
EE05444B1 (et) 2011-08-15
DE60103503T3 (de) 2008-12-24
BG106943A (bg) 2003-02-28
AR027287A1 (es) 2003-03-19
MXPA02007233A (es) 2003-02-12
EA004924B1 (ru) 2004-10-28
SK287717B6 (en) 2011-07-06
KR20070087253A (ko) 2007-08-27
IL150837A (en) 2010-12-30
ES2217113T5 (es) 2008-11-01
CZ20022555A3 (cs) 2002-11-13
ATE267608T1 (de) 2004-06-15
BR0107881A (pt) 2003-04-01
HUP0204324A3 (en) 2004-12-28
KR100871499B1 (ko) 2008-12-05
HU230833B1 (hu) 2018-07-30
EP1250148B2 (en) 2008-07-02
NO324626B1 (no) 2007-11-26
HUP0204324A2 (en) 2003-05-28
SI1250148T1 (en) 2004-08-31
YU56702A (sh) 2005-09-19
DE60103503T2 (de) 2005-06-09
KR100871502B1 (ko) 2008-12-05
BG65915B1 (bg) 2010-05-31
EP1250148A1 (en) 2002-10-23
CN1418107A (zh) 2003-05-14
SK10962002A3 (sk) 2002-12-03
IL150837A0 (en) 2003-02-12
NO20023354D0 (no) 2002-07-11
JP5170928B2 (ja) 2013-03-27
US20030158106A1 (en) 2003-08-21
US7291593B2 (en) 2007-11-06
RS50805B (sr) 2010-08-31
WO2001054715A1 (en) 2001-08-02
EE200200415A (et) 2003-12-15
EP1250148B1 (en) 2004-05-26

Similar Documents

Publication Publication Date Title
PT1102763E (pt) Mimeticos fsh para o tratamento da infertilidade
PT1147083E (pt) Derivados de arilpiperazinil-ciclohexilindole para o tratamento da depressao
PT1144395E (pt) Derivados de 2-aminobenzoxazinona para o tratamento da obesidade
PT1143977E (pt) Derivados de 2-oxibenzoxazinona para o tratamento da obesidade
ATE349956T1 (de) Ringfixateur
ATA15802000A (de) Pinzette
MXPA02004770A (es) Composiciones terapeuticas y metodos para su uso.
BR0105828B1 (pt) dispositivo para locomoÇço de deficientes fÍsicos.
PT1206436E (pt) Retinoides para o tratamento de enfisema
BR0112441B1 (pt) aparelho para esmerilhar.
DE60135797D1 (de) Kunstleder
DE60142184D1 (de) Bewegliches körpersystem
PT1250148E (pt) Uso de fsh para o tratamento da infertilidade
AR027954A1 (es) Encendedor de uso general
PT1220858E (pt) Oxazinoquinolonas uteis para o tratamento de infeccoes virais
PT1268482E (pt) Piranoindois para o tratamento de glaucoma
AR028398A1 (es) Ciclipostinas, procedimiento para su preparacion, y utilizacion de las mismas
AR028550A1 (es) Procedimiento para la obtencion de caprolactama
PT1148874E (pt) Uso de derivados anticonvulsivos para o tratamento da bulimia nervosa
DE50101155D1 (de) Gerbstoff-/Nachgerbstoffpräparationen
ES1047686Y (es) Mecanismo de bloqueo del resbalon para picaportes.
ES1046497Y (es) Escurridor para mochos
ES1045721Y (es) Aparato de electromedicina
ES1041027Y (es) Dispositivo de soporte para cuadros o similares.
ES1045503Y (es) Estructura mejorada para expositores de piezas ceramicas.